322 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLNX | €32.54 | 3.3% | -4.5% | €23.0b | €44.03 | PS5.7x | E73.2% | 0.2% | Telecom | ||
ILMN | US$140.14 | 7.2% | 48.1% | US$22.2b | US$164.60 | PS5.1x | E70.4% | 2.2% | Pharmaceuticals & Biotech | ||
000002 | CN¥8.38 | -5.2% | -29.0% | CN¥93.9b | CN¥7.28 | PS0.3x | E93.1% | 0% | Real Estate Management and Development | ||
ADE | NOK 114.20 | 0.4% | 41.5% | NOK 139.1b | NOK 113.94 | PS6.5x | E83.0% | n/a | Media | ||
GALD | CHF 87.65 | 2.9% | n/a | CHF 20.8b | CHF 93.19 | PS5.4x | E44.4% | n/a | Pharmaceuticals & Biotech | ||
1COV | €57.10 | -0.2% | 17.4% | €10.8b | €60.92 | PS0.8x | E62.2% | 0% | Materials | ||
APG New | US$37.01 | 3.6% | 21.8% | US$10.2b | US$43.22 | PS1.5x | E87.9% | n/a | Capital Goods | ||
4755 | JP¥879.40 | -2.3% | 52.2% | JP¥1.9t | JP¥977.67 | PS0.9x | E83.2% | 0% | Retail | ||
LPLA | US$326.85 | 3.8% | 41.7% | US$24.5b | US$309.13 | PE24.3x | E13.5% | 0.4% | Diversified Financials | ||
DSFIR | €107.25 | 4.7% | 21.3% | €28.5b | €128.96 | PS2.3x | E43.6% | 0.9% | Materials | ||
2002 | NT$22.20 | -1.1% | -15.1% | NT$337.0b | NT$23.83 | PE86.6x | E59.3% | 1.6% | Materials | ||
UN0 | €41.55 | -2.0% | -48.8% | €17.3b | €35.83 | PS0.2x | E64.7% | 0% | Utilities | ||
ALO | €21.05 | -5.2% | 72.3% | €9.7b | €22.76 | PS0.5x | E58.2% | 0% | Capital Goods | ||
A035720 | ₩36,350.00 | 3.6% | -27.1% | ₩15.8t | ₩47,546.67 | PS2x | E66.9% | 0.2% | Media | ||
GMED | US$84.72 | 3.5% | 83.9% | US$11.5b | US$90.54 | PE126.1x | E49.0% | n/a | Healthcare | ||
PHIA | €25.22 | 2.6% | 32.5% | €23.6b | €28.67 | PS1.3x | E60.9% | n/a | Healthcare | ||
CIEN New | US$70.13 | 5.3% | 55.2% | US$10.1b | US$65.73 | PE73.3x | E39.5% | n/a | Tech | ||
COHR | US$105.34 | 10.5% | 190.5% | US$16.3b | US$109.50 | PS3.3x | E110.2% | n/a | Tech | ||
TWLO | US$104.35 | 8.2% | 66.0% | US$16.0b | US$84.95 | PS3.7x | E86.6% | n/a | Software | ||
UCB | €180.00 | 8.4% | 160.9% | €34.1b | €176.22 | PE142.3x | E35.9% | 0.8% | Pharmaceuticals & Biotech | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
6502 | JP¥4,590.00 | 0% | 5.2% | JP¥2.0t | JP¥4,606.67 | PS0.6x | E81.9% | 0% | Capital Goods | ||
FND | US$112.00 | 9.3% | 21.9% | US$12.0b | US$104.04 | PE61.4x | E17.6% | n/a | Retail | ||
VRTX | US$450.97 | -3.4% | 28.8% | US$116.1b | US$514.81 | PS10.9x | E47.4% | n/a | Pharmaceuticals & Biotech |